Uncategorized
Latest Iluvien data similar to trial results
Patients with chronic diabetic macular edema treated with an Iluvien implant experienced an average visual acuity increase from 51.9 letters at baseline to 57.2 letters at 24-month follow-up, with IOP-related adverse events occurring at a similar frequency as those reported in the FAME study.Fourteen United Kingdom clinics contributed data comparing real-world safety and visual function outcomes in eyes treated with an Iluvien implant (0.2µg per day fluocinolone acetonide, Alimera Sciences). Three hundred forty-five eyes of 305 patients with chronic DME had a mean follow-up of 428 days.